Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 23251285)

2.

A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group.

Branch DW, Peaceman AM, Druzin M, Silver RK, El-Sayed Y, Silver RM, Esplin MS, Spinnato J, Harger J.

Am J Obstet Gynecol. 2000 Jan;182(1 Pt 1):122-7.

PMID:
10649166
3.

Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome.

Bramham K, Hunt BJ, Germain S, Calatayud I, Khamashta M, Bewley S, Nelson-Piercy C.

Lupus. 2010 Jan;19(1):58-64. doi: 10.1177/0961203309347794. Epub 2009 Nov 6.

PMID:
19897518
4.

Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin.

Vaquero E, Lazzarin N, Valensise H, Menghini S, Di Pierro G, Cesa F, Romanini C.

Am J Reprod Immunol. 2001 Mar;45(3):174-9.

PMID:
11270643
5.

Prevention of fetal death in the antiphospholipid antibody syndrome.

Cowchock S.

Lupus. 1996 Oct;5(5):467-72. Review.

PMID:
8902784
6.

The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women.

Le Thi Thuong D, Tieulié N, Costedoat N, Andreu MR, Wechsler B, Vauthier-Brouzes D, Aumaître O, Piette JC.

Ann Rheum Dis. 2005 Feb;64(2):273-8. Review.

7.

Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.

Dendrinos S, Sakkas E, Makrakis E.

Int J Gynaecol Obstet. 2009 Mar;104(3):223-5. doi: 10.1016/j.ijgo.2008.11.010. Epub 2008 Dec 29.

PMID:
19116178
8.

Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial.

Pattison NS, Chamley LW, Birdsall M, Zanderigo AM, Liddell HS, McDougall J.

Am J Obstet Gynecol. 2000 Oct;183(4):1008-12.

PMID:
11035355
9.

Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment.

Farquharson RG, Quenby S, Greaves M.

Obstet Gynecol. 2002 Sep;100(3):408-13. Erratum in: Obstet Gynecol 2002 Dec;100(6):1361.

PMID:
12220757
10.

Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin.

Stephenson MD, Ballem PJ, Tsang P, Purkiss S, Ensworth S, Houlihan E, Ensom MH.

J Obstet Gynaecol Can. 2004 Aug;26(8):729-34.

PMID:
15307977
11.

Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.

Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L.

Am J Obstet Gynecol. 1992 May;166(5):1318-23.

PMID:
1595785
12.

Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy.

Botet F, Romera G, Montagut P, Figueras J, Carmona F, Balasch J.

J Perinat Med. 1997;25(2):192-6.

PMID:
9189840
13.

Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience.

Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR.

Obstet Gynecol. 1992 Oct;80(4):614-20.

PMID:
1407882
14.

A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.

Tempfer CB, Kurz C, Bentz EK, Unfried G, Walch K, Czizek U, Huber JC.

Fertil Steril. 2006 Jul;86(1):145-8. Epub 2006 May 23.

PMID:
16716321
15.

Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.

Triolo G, Ferrante A, Ciccia F, Accardo-Palumbo A, Perino A, Castelli A, Giarratano A, Licata G.

Arthritis Rheum. 2003 Mar;48(3):728-31.

16.

Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.

Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA, Kingdom JC, Barrett J, Gent M.

J Rheumatol. 2009 Feb;36(2):279-87. doi: 10.3899/jrheum.080763).

PMID:
19208560
17.

Antibody profile of pregnant women with antiphospholipid syndrome and pregnancy outcome after treatment with low dose aspirin and low-weight-molecular heparin.

Glasnović M, Bosnjak I, Vcev A, Soldo I, Kosuta M, Lenz B, Glasnović-Horvatić E, Soldo-Butković S, Mićunović N.

Coll Antropol. 2007 Mar;31(1):173-7.

PMID:
17598397
18.

Primary antiphospholipid syndrome: pregnancy outcome in a portuguese population.

Serrano F, Nogueira I, Borges A, Branco J.

Acta Reumatol Port. 2009 Jul-Sep;34(3):492-7.

19.

A study of sixty pregnancies in patients with the antiphospholipid syndrome.

Lima F, Khamashta MA, Buchanan NM, Kerslake S, Hunt BJ, Hughes GR.

Clin Exp Rheumatol. 1996 Mar-Apr;14(2):131-6.

PMID:
8737718
20.

Plasmapheresis and pregnancy outcome in patients with antiphospholipid syndrome.

El-Haieg DO, Zanati MF, El-Foual FM.

Int J Gynaecol Obstet. 2007 Dec;99(3):236-41. Epub 2007 Sep 25.

PMID:
17897649
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk